The rapid advancement of digital technologies and artificial intelligence is reshaping how healthcare providers operate worldwide. In this context, the establishment of Clinicore GmbH by Croma-Pharma GmbH and Medfile marks an important step toward integrating aesthetic medicine with advanced IT solutions.

Clinicore is built on the combination of a global aesthetic medicine leader’s expertise and the technological capabilities developed within the Biostat Group. Strong R&D foundations and experience in medical software development form the backbone of a platform designed to support modern clinics.

Technology and medical expertise combined

Medfile, developed within Biostat, is an advanced practice management system that integrates operational workflows with artificial intelligence. It includes tools supporting medical documentation, a physician voice assistant, and solutions designed to enhance clinical decision-making processes.

Croma brings extensive experience in the development and distribution of aesthetic medicine products, including botulinum toxin, PDO threads, polynucleotide injectables, and hyaluronic acid-based skin boosters.

The combination of these competencies creates a foundation for a comprehensive technological ecosystem tailored to the needs of modern aesthetic clinics.

Clinicore – addressing real market needs

The newly established company focuses on developing a solution that responds to the key challenges faced by aesthetic medicine providers. The platform aims to:

• reduce administrative burden,
• increase physicians’ efficiency,
• enable greater focus on patient care,
• leverage the potential of artificial intelligence and large language models (LLMs).

From the outset, Clinicore is designed as a scalable solution ready for international markets.

Shared vision of the partners

We are excited to leverage our extensive experience and competencies in developing medical software and applying LLM technologies in the field of aesthetic medicine. We are confident that, together with such a strong partner as Croma, we will be able to create even more innovative solutions,

“Clinicore is more than a partnership; it’s a catalyst for the digital evolution of our industry. By merging Croma’s heritage in aesthetic excellence with Medfile’s cutting-edge AI, we are not just expanding our portfolio—we are redefining how physicians interact with technology to enhance patient outcomes worldwide.

Biostat – R&D and technology backbone

The Clinicore project aligns with Biostat’s long-term strategy of integrating expertise in research, data analysis, and healthcare software development.

As a research and development center, Biostat supports both clinical and observational studies while also delivering advanced IT solutions for healthcare providers. Participation in Clinicore reflects a natural progression toward building scalable, data-driven technologies for global healthcare markets.

A new stage in the digitalization of aesthetic medicine

The establishment of Clinicore GmbH represents another milestone in the digital transformation of aesthetic medicine—from clinic management and medical documentation to advanced clinical decision support.

The ambition of the partners is clear: to develop solutions that will become a global standard for aesthetic medicine providers, combining medical expertise, data, and artificial intelligence within a unified technological environment.